03681.HK
SinoMab BioScience Limited
HKSE · Healthcare · Biotechnology · HK
HKD 1.13
−2.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.65x
- Price / sales
- —
- Price / cash flow
- -18.71x
Enterprise value
- Enterprise value
- HKD 1.6B
- EV / sales
- —
- EV / EBITDA
- -8.89x
- EV / EBIT
- -8.51x
- Market cap
- HKD 1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026